Rhesus, in its most common medical usage, refers to the Rh blood group system, a set of proteins on the surface of red blood cells that determine whether a person’s blood type is “positive” or “negative.” The name traces directly to the rhesus macaque, a monkey species whose blood helped scientists identify the first of these proteins in 1940. Though the connection to monkeys surprises many people, the Rh system turns out to be far more than a simple plus or minus on a blood test: it involves dozens of antigens, plays a structural role in keeping red blood cells intact, and carries serious consequences during pregnancy and transfusion.
How a Monkey Gave Its Name to Your Blood Type
In 1940, Karl Landsteiner and Alexander Wiener injected red blood cells from rhesus macaques into rabbits and guinea pigs, then collected the serum those animals produced. When they mixed that serum with human blood samples, it caused the red blood cells in most samples to clump together, a reaction called agglutination. The protein responsible for that clumping was dubbed the “Rh factor” after the rhesus monkey that made the experiment possible.1Journal of Clinical Surgery and Research. Blood Types and Human Rh Factor: History, Heroes, In Reflection of a Number of Collectibles If your red blood cells carry this protein, you are Rh-positive; if they do not, you are Rh-negative.
The rhesus macaque (Macaca mulatta) earned its place in the story partly by being abundant and easy to work with in laboratories, and partly by being closely related enough to humans for the cross-species experiment to reveal something useful. Researchers later established that rhesus macaques diverged from our lineage roughly 25 million years ago, yet remain genetically and physiologically similar enough to serve as stand-ins for human biology across a wide range of diseases.2PubMed. Evolutionary and biomedical insights from the rhesus macaque genome The Rh blood group system was just one of the first major medical discoveries to come from that similarity.
What the Rh Factor Actually Is
When people say “Rh-positive” or “Rh-negative,” they are almost always talking about a single antigen called the D antigen. It is the most immunologically potent of all the Rh antigens, meaning the human immune system reacts to it more strongly than to the others. But the full Rh system is considerably more complex: it involves two closely related genes, RHD and RHCE, which together encode more than 280 known variants.3Genetics in Medicine. Genomic characterization of the RH locus detects complex and novel structural variation in multi-ethnic cohorts The RHD gene produces the D antigen, while RHCE produces the C, c, E, and e antigens. All of these sit on the red blood cell membrane, but D gets nearly all the clinical attention because of its powerful ability to trigger an immune response.
Being Rh-negative usually means a person’s RHD gene is entirely deleted. This is the most common mechanism in people of European ancestry. In people of African descent, the picture is more varied: partial RHD genes, inactive copies (pseudogenes), and hybrid genes that fuse portions of RHD and RHCE are all found at meaningful frequencies.4PubMed Central. The genetics of the Rhesus blood group system This genetic diversity matters for transfusion medicine because some of those variant genes can produce partial or weakened versions of the D antigen, creating gray areas in blood typing.
Beyond Blood Typing: What Rh Proteins Do in the Body
The Rh proteins are not just sitting on red blood cells waiting to be typed. They form a larger complex with several partner proteins, including one called RhAG, and together this group helps maintain the physical shape and flexibility of red blood cells. By connecting to the internal skeleton of the cell through structural proteins, the Rh complex keeps the membrane stable and able to squeeze through the narrowest capillaries without tearing apart.5PubMed. Rh proteins: key structural and functional components of the red cell membrane
On top of that structural role, the Rh proteins appear to function as gas channels. RhAG, in particular, has been shown to help move ammonia across the red blood cell membrane. This is thought to play a part in shuttling ammonia to organs like the kidneys and liver, where it can be broken down, and may also help regulate the body’s acid-base balance.6PubMed Central. Human Rhesus-associated glycoprotein mediates facilitated transport of NH(3) into red blood cells The broader Rh protein family, in fact, belongs to an ancient group of membrane proteins involved in ammonia transport that stretches back through evolutionary history well beyond mammals.7PubMed Central. The structure and function of the Rh antigen complex
These functions help explain why losing Rh proteins entirely (a rare condition discussed later) does not just change a blood type label. It destabilizes the red blood cell membrane itself, leading to chronic anemia.
Why Rh Status Matters Most During Pregnancy
The D antigen’s strong immunogenicity creates real danger in one specific scenario: when an Rh-negative mother carries an Rh-positive fetus. If fetal blood cells cross the placenta and enter the mother’s bloodstream, her immune system can recognize the D antigen as foreign and build antibodies against it. About 80% of Rh-negative people who receive Rh-positive red blood cells develop anti-D antibodies, and the D antigen is involved in roughly 95% of cases of hemolytic disease of the newborn.8PubMed Central. Fetal–maternal incompatibility in the Rh system. Rh isoimmunization associated with hereditary spherocytosis: case presentation and review of the literature
This condition, historically called “Rh disease,” was a major cause of severe illness and death in fetuses and newborns throughout the mid-twentieth century. The immune attack typically does not affect the first pregnancy (the mother’s body needs time to mount a full antibody response), but in subsequent pregnancies with an Rh-positive fetus, those pre-formed antibodies can cross the placenta and destroy fetal red blood cells.9PLOS ONE. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children
The introduction of Rh immune globulin (commonly known by the brand name RhoGAM) changed this dramatically. Given to Rh-negative mothers during and after pregnancy, it prevents the immune system from sensitizing to the D antigen in the first place. Combined with strict transfusion compatibility rules, this preventive measure has slashed the incidence of Rh disease in countries where it is routinely available.10The Review of Diabetic Studies. Rh Blood Group System: Clinical Significance, Laboratory Testing, and Transfusion Safety The disease has not disappeared, though. In parts of the world where Rh immune globulin is less accessible, and in cases where the first sensitizing event goes undetected, it continues to cause harm.
How Common Is Rh-Negative Blood?
Rh-negative status is unevenly distributed around the world. Among people of European descent, about 15% are Rh-negative. In populations from East Asia and among many Indigenous peoples, the frequency is much lower, sometimes below 1%. A large multicenter study across India found that about 5.4% of blood donors were Rh-negative, with regional variation ranging from roughly 4.8% to 7%.11PubMed Central. ABO and Rh (D) group distribution and gene frequency; the first multicentric study in India
This wide variation has puzzled evolutionary biologists. Being Rh-negative offers no obvious survival advantage and carries the reproductive disadvantage of potential hemolytic disease of the newborn. Yet the Rh-negative trait has persisted in some populations at high frequencies for thousands of years. Studies of Rh gene evolution across primate species have found evidence of positive selection, meaning that natural selection at some point favored changes in these genes, though the exact pressures are not fully understood.12PubMed. Evolution of Rh blood group genes have experienced gene conversions and positive selection The related RhAG gene, which encodes the ammonia-transport partner protein, also shows signs of positive selection during the evolution of primates, evolving at about half the speed of the Rh30 polypeptides (the D and CcEe proteins themselves), which suggests that its function is under tighter evolutionary constraint.13PubMed. Sequence, organization, and evolution of Rh50 glycoprotein genes in nonhuman primates
The Gray Area of Weak D and Partial D
Blood typing is often presented as binary: you either have the D antigen or you don’t. In reality, some people carry altered versions of the D antigen that do not fit neatly into positive or negative categories. These fall into two main groups: “weak D” and “partial D.”
People with weak D produce a normal D protein, but in smaller quantities. Research measuring D antigen density on individual red blood cells has found that weak D types carry anywhere from about 70 to 4,000 D copies per cell, compared to tens of thousands on a normal Rh-positive cell.14Blood. Weak D alleles express distinct phenotypes Some of the most common weak D types are clinically harmless: people who carry them rarely develop anti-D antibodies and generally do not need Rh-negative blood for transfusions. But rarer weak D types carry D antigens that are altered enough to potentially trigger an immune response, making them behave more like partial D phenotypes. Partial D individuals are missing portions of the D antigen, so their immune systems can recognize the missing parts as foreign if they encounter a complete D antigen through transfusion or pregnancy.
The practical upshot is that some donors and patients need molecular genotyping, not just a standard serologic blood test, to determine how they should be managed. Standard antibody-based tests may call a weak D person “Rh-positive” or give an ambiguous result, but the clinical question that actually matters is whether that person’s immune system could make anti-D antibodies. Increasingly, transfusion services are using DNA-based methods to make that call.
Rh-Null, the Rarest Blood Type
At the extreme end of the Rh spectrum sits Rh-null, sometimes called “golden blood” in popular media because of its extraordinary rarity. People with Rh-null blood lack all Rh antigens on their red blood cells, not just D, but C, c, E, and e as well. Fewer than 50 individuals worldwide have been identified with this phenotype. The condition comes in two genetic forms: an “amorph” type, where the RHD and RHCE genes themselves are nonfunctional, and a “regulator” type, where a mutation in the RHAG gene prevents the entire Rh complex from being assembled on the cell surface.15Blood. Rhnull Syndrome: Identification of a Novel Mutation in RHce Gene
Because the Rh proteins are critical to the structure of the red blood cell membrane, losing them entirely causes real health problems. People with Rh-null syndrome typically have chronic mild hemolytic anemia, meaning their red blood cells break down faster than normal. Their cells take on an abnormal shape called stomatocytes (mouth-shaped cells) and show increased fragility when placed in solutions of varying salt concentration.16PubMed Central. First Report of Known Rare Rhnull Phenotype Individuals in Iran Detailed laboratory studies of Rh-null red blood cells have shown that they also lose surface area faster as they age in circulation and have abnormal regulation of sodium and potassium, with pumps working at roughly twice the normal rate to try to compensate.17Blood. Red cell membrane and cation deficiency in Rh null syndrome
The transfusion challenge for Rh-null individuals is severe. They can only safely receive blood from other Rh-null donors, an almost impossibly small pool. In practice, some Rh-null patients have been encouraged to bank their own blood in advance of any planned surgery, and international registries help connect the handful of known donors.
How Doctors Test Fetal Rh Status Without Invasive Procedures
One of the more practical advances in Rh medicine over the past two decades is the ability to determine a fetus’s Rh status from a simple blood draw from the mother. Small fragments of fetal DNA circulate in a pregnant woman’s blood, and laboratory tests can detect whether those fragments include a functional RHD gene. As a screening tool, this approach achieves sensitivity above 99.3% from around 10 to 11 weeks of pregnancy.18PubMed. Noninvasive fetal RhD genotyping
This matters because it allows doctors to target Rh immune globulin prophylaxis only to those Rh-negative women actually carrying an Rh-positive fetus. Before noninvasive testing was available, all Rh-negative pregnant women received the injections as a precaution, which meant that about 40% of them (those carrying Rh-negative fetuses) were getting unnecessary treatment. Newer quantitative lab methods have further refined the precision of these tests, making it possible to confidently determine fetal Rh status from extremely small amounts of circulating DNA.19PLOS ONE. Performance of Droplet Digital PCR in Non-Invasive Fetal RHD Genotyping – Comparison with a Routine Real-Time PCR Based Approach Several European countries have already implemented nationwide screening programs using this technology, and broader adoption is ongoing.
The Rhesus Macaque’s Wider Role in Medicine
The rhesus macaque’s contribution to human health extends well beyond lending its name to a blood group. It remains the most commonly used nonhuman primate in biomedical research, serving as a model for diseases including HIV, obesity, and cognitive aging.20PubMed Central. Laboratory rhesus macaque social housing and social changes: Implications for research Much of what we know about the immune system, vaccine development, and reproductive biology has come from studies in rhesus macaques, in large part because they breed reliably in captivity and their physiology tracks closely with ours.
That widespread use has also generated ongoing ethical scrutiny. Legal frameworks in many countries require ethical review before rhesus macaques can be enrolled in research, and guidelines emphasize continual refinement of housing and handling to improve animal welfare. Quantitative data on the effectiveness of welfare protocols remains limited, however, which has pushed researchers to develop better metrics for evaluating how specific enrichment strategies affect the animals’ well-being.21bioRxiv. Quantitative evaluation of enrichment protocols on rhesus macaques welfare in laboratory environment The tension between the macaque’s extraordinary scientific utility and the ethical costs of using it is unlikely to resolve cleanly anytime soon, but it shapes how the animal is housed, studied, and discussed in nearly every research institution that works with primates.